In practice, the way people feel about windmills may have as much to do
with financial effects as with physical ones.
Bankruptcy leaves a lingering black mark on your credit history,
with the financial effects lasting for several years.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions
with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the
effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the
effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the
effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements
with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements
with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts
with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the
effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the
effect of changes in tax law, such as the
effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the
effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships
with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over
financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance
with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
The license agreement allowing Spielberg to keep using the name DreamWorks took
effect Jan. 1, 2009, when DreamWorks ended its distribution agreement
with Paramount and turned to Disney for distribution and India's Reliance for
financial backing.
«It's ironic, because if you look at his proposed tax plan, he is in
effect leaving the AMT system in place,» said Marianela Collado, CPA and CFP
with Tobias
Financial Advisors.
Investors
with a fixed - income allocation in their portfolio should meet
with their
financial professional to ensure they understand the
effect of rising interest rates on their overall portfolio, she said.
These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree
with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's
financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side
effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company
with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.
Michigan law grants emergency
financial managers expansive authority, and a law to take
effect March 28 will boost those powers, allowing Orr to terminate collective bargaining agreements
with the city's 48 unions.
Such risks, uncertainties and other factors include, without limitation: (1) the
effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including
financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel,
financial condition of commercial airlines, the impact of weather conditions and natural disasters and the
financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection
with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection
with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection
with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the
effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the
effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the
effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative
effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective
financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in
effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection
with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated
with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated
with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.
The proposed delay should have a «calming»
effect on the marketplace, which had been «hanging in limbo» ahead of the April 10 effective date, said Denise Valentine, a senior analyst
with Aite Group, which advises the
financial services industry on regulatory issues.
With Becky Quick hosting, regular features include interviews with top financial executives & policy makers, discussions of current business trends & effects on consumers, stock picks, personal - finance suggestions and reviews of new produ
With Becky Quick hosting, regular features include interviews
with top financial executives & policy makers, discussions of current business trends & effects on consumers, stock picks, personal - finance suggestions and reviews of new produ
with top
financial executives & policy makers, discussions of current business trends &
effects on consumers, stock picks, personal - finance suggestions and reviews of new products.
The Healthcare Reform Law, including The Patient Protection and Affordable Care Act and The Healthcare and Education Reconciliation Act of 2010, could have a material adverse
effect on Humana's results of operations, including restricting revenue, enrollment and premium growth in certain products and market segments, restricting the company's ability to expand into new markets, increasing the company's medical and operating costs by, among other things, requiring a minimum benefit ratio on insured products, lowering the company's Medicare payment rates and increasing the company's expenses associated
with a non-deductible health insurance industry fee and other assessments; the company's
financial position, including the company's ability to maintain the value of its goodwill; and the company's cash flows.
For its internal budgeting process, and as discussed further below, Cree's management uses
financial statements that do not include the items listed below and the income tax
effects associated
with the foregoing.
Actual results may differ materially from those indicated by these forward - looking statements as a result of various important factors including, but not limited to, the
effects of any unexpected difficulty in closing our
financial books for the quarter and other factors that are discussed in the Company's Annual Report on Form 10 - K, quarterly reports on Form 10 - Q, and other documents periodically filed
with the SEC.
The most famous sect of the rules is set to take
effect later this year, and would require wireline and mobile ISPs like Comcast and AT&T to ensure customers opt - in to any programs that share their web browsing and app usage histories, mobile location data,
financial data, and other «sensitive» info
with third parties for marketing purposes.
«We are aware that there could be negative ripple
effects should geopolitical risks resurface,» Kim Dong - yeon told a hastily arranged policy meeting
with the central bank and
financial regulators before
financial markets opened.
These breach disclosures affirm the wisdom of New York state implementing its trailblazing cybersecurity rules for
financial services firms that took
effect last March, and which were amended
with the SHIELD act in November.
Important factors that could cause our actual results and
financial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on For
financial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and services; the
effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the
effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply
with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of
Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on For
Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 10 - Q.
With headaches like natural disasters, rising wages in China, and a financial domino effect gripping economies around the world — not to mention recession - induced protectionism like U.S. President Barack Obama's jobs bills with their Buy American clauses — have we reached the limits of the global integration that has propelled the world economy since the end of the Cold
With headaches like natural disasters, rising wages in China, and a
financial domino
effect gripping economies around the world — not to mention recession - induced protectionism like U.S. President Barack Obama's jobs bills
with their Buy American clauses — have we reached the limits of the global integration that has propelled the world economy since the end of the Cold
with their Buy American clauses — have we reached the limits of the global integration that has propelled the world economy since the end of the Cold War?
Today's
financial market volatility, combined
with great political uncertainty both at home and abroad, will undoubtedly have an
effect on consumer confidence and perhaps even our customers» attitudes and behavior.
EY's report concludes this emphasis on frugality is because Gen Z have matured in the aftermath of the
financial crisis and, having seen the recession's
effect on their families, are more careful
with their money.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018
financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations
with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the
effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination
with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed
with the U.S. Securities and Exchange Commission (the SEC).
an independent agency of the federal government, created in 1933, charged
with preserving and promoting public confidence in the U.S.
financial system by insuring deposits in banks and thrift institutions up to applicable limits; by identifying, monitoring, and addressing risks to the deposit insurance funds; and by limiting the
effect on the economy and the
financial system when a bank or thrift institution fails; further information on the FDIC and FDIC coverage may be found at fdic.gov
This means that the framework shouldn't have lasting unintended
effects on how people invest their money or on how
financial institutions interact
with each other.
Adjusted Revenue is a non-GAAP
financial measure that we define as our total net revenue less transaction costs, adjusted to eliminate the
effect of activity under our payment processing agreement
with Starbucks.
Such risks and uncertainties include, but are not limited to: our ability to achieve our
financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships
with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including
with respect to the Merger; the substantial level of government regulation over our business and the potential
effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated
with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger;
effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.
Financial problems
with General Electric's run - off insurance block will not
effect Genworth
Financial's long - term care insurance (LTCi) policies that were reinsured to a GE subsidiary, execs say.
Unfortunately, the article concludes that federal corporate governance regulation follows a ratchet
effect, in which the regulatory scheme becomes more complex
with each
financial crisis.
This phenomenon is highly interrelated
with Iraq, ISIS, the 2008
financial crash, UK's shocking Brexit, immigration and ultimately the Trump
Effect.
The «January
effect,» in common
with the «Halloween indicator» and «sell in May and go away», is a catchy, get - rich - quick investment idea adored by
financial commentators because it is so easy to explain to unsophisticated readers.
on a pro forma basis, giving
effect to (i) the automatic conversion of all of our outstanding shares of convertible preferred stock other than Series FP preferred stock into shares of Class B common stock and the conversion of Series FP preferred stock into shares of Class C common stock in connection
with our initial public offering, (ii) stock - based compensation expense of approximately $ 1.1 billion associated
with outstanding RSUs subject to a performance condition for which the service - based vesting condition was satisfied as of December 31, 2016 and which we will recognize on the effectiveness of our registration statement in connection
with a qualifying initial public offering, as further described in Note 1 to our consolidated
financial statements included elsewhere in this prospectus, (iii) the increase in accrued expenses and other current liabilities and an equivalent decrease in additional paid - in capital of $ 187.2 million in connection
with the withholding tax obligations, based on $ 16.33 per share, which is the fair value of our common stock as of December 31, 2016, as we intend to issue shares of Class A common stock and Class B common stock on a net basis to satisfy the associated withholding tax obligations, (iv) the net issuance of 7.6 million shares of Class A common stock and 5.5 million shares of Class B common stock that will vest and be issued from the settlement of such RSUs, (v) the issuance of the CEO award, as described below, and (vi) the filing and effectiveness of our amended and restated certificate of incorporation which will be in
effect on the completion of this offering.
The pro forma consolidated balance sheet data gives
effect to (i) the automatic conversion of all of our outstanding shares of convertible preferred stock other than Series FP preferred stock into shares of Class B common stock and the conversion of Series FP preferred stock into shares of Class C common stock in connection
with our initial public offering, (ii) stock - based compensation expense of approximately $ 1.1 billion associated
with outstanding RSUs subject to a performance condition for which the service - based vesting condition was satisfied as of December 31, 2016 and which we will recognize on the effectiveness of our registration statement in connection
with this offering, as further described in Note 1 to our consolidated
financial statements included elsewhere in this prospectus, (iii) the increase in accrued expenses and other current liabilities and an equivalent decrease in additional paid - in capital of $ 187.2 million in connection
with the withholding tax obligations, based on $ 16.33 per share, which is the fair value of our common stock as of December 31, 2016, as we intend to issue shares of Class A common stock and Class B common stock on a net basis to satisfy the associated withholding tax obligations, (iv) the net issuance of 7.6 million shares of Class A common stock and 5.5 million shares of Class B common stock that will vest and be issued from the settlement of such RSUs, (v) the issuance of the CEO award, as described below, and (vi) the filing and effectiveness of our amended and restated certificate of incorporation which will be in
effect on the completion of this offering.
The company believes that after giving
effect to the restatement, it will have remained in compliance
with all of the
financial maintenance covenants in its credit facility at the end of each affected quarterly period.
Can investing in companies
with favorable gender diversity records
effect change and produce positive
financial returns?
The observed
effects are compatible
with field observations in professional traders and suggest that these hormones may play a destabilizing role in
financial markets.
When the beneficial owner rule goes into
effect May 11,
financial institutions covered by it will have to start identifying and verifying all «beneficial owners» of business entities who want to do business
with them, including applying for business credit.
Before this rule went into
effect, an advisor may have recommended
financial products that are pretty good for you, but might have come
with higher fees or commissions that benefit them.
«The academic world still insists on teaching that
financial markets are largely efficient,
with perhaps a few minor anomalies (such as the «January
effect») that give tenure - seeking finance professors something to research» Seth Klarman
During my hiatus, I spoke
with Rick Santelli (click on the image below) to discuss some of the new issues presenting investment opportunities, in addition to concerns surrounding potential negative fallout from ill - conceived models, such as the
effect of the border adjustment tax on the global
financial system.
The event caused a knock - on
effect across the country's exchange sector, the
Financial Services Agency (FSA) subsequently inspecting, punishing and even shutting down various operators over noncompliance
with regulations.
Unfortunately, global
financial markets are now undergoing a pronounced reduction in the bio-diversity of market service providers,
with deleterious
effects on market safety and soundness.
Tariffs are taxing the global
financial markets as they try to guesstimate the economic impact from the
effect of tit - for - tat responses to the initial U.S. measures efforts to gain support for dealing
with Chinese trade violations.
With recent instability in global
financial markets and the ripple
effect into Asia due to macro factors.
Nevertheless, there were numerous critics expressing worries about the growth of margin lending, but the
financial press tended to play their arguments down, even going as far as charging the critics
with trying to undermine confidence for ulterior reasons (Barron's and the Wall Street Journal both published editorials to that
effect).
Using the change in the underlying cash balance between
financial years as an approximate indicator of the fiscal impact, the Commonwealth Budget is expected to add to growth by around 1/4 per cent of GDP this
financial year, compared
with a contractionary
effect of around 3/4 per cent in 2002/03 (Graph 32).
Many health care analysts are concerned about the
financial effect of the Affordable Care Act on health insurers, especially those
with large exposure to Medicare and Medicaid such as Aetna.
Income reporting would instead show that short - term corrections have little
effect on long - term outcomes, giving participants the potential encouragement to stay the course
with their
financial plan.
Sutton predicts that this «Uber
Effect» will occur
with artificial intelligence and the
financial industry, especially in the retail banking industry where there will be a blur between retail banks and wealth managers.
StartEngine is one of the first applicants to begin the process to become a registered Funding Portal
with the SEC and, when available in February, will apply to become a member of the
Financial Industry Regulatory Authority (FINRA) under the historic rules which were approved last October and will go into
effect on May 16, 2016, allowing entrepreneurs to raise up to $ 1M per year via equity crowdfunding from all investors.
So, we see a major
financial and economic crisis beginning
with deflation in a certain number of countries such as Japan, which had major
effects on countries such as South Korea and Brazil, and also on developed countries where all the countries of the North and South are starting to move into recession.